Skip to main content
. 2023 Dec 1;108(12):3244–3260. doi: 10.3324/haematol.2023.282717

Table 4.

Anti-PD-1 and PD-L1 therapies in relapsed/refractory extranodal NK/T-cell lymphoma.

graphic file with name 1083244.tab4.jpg